Skip to content
2000
Volume 22, Issue 3
  • ISSN: 1567-2026
  • E-ISSN: 1875-5739

Abstract

Introduction

Hemorrhagic stroke is a severe disease that endangers human life and well-being, with unclear pathogenesis. Recent studies have found an association between the immune system and hemorrhagic stroke, but the causal relationship between them remains unclear. We aim to elucidate the causal relationships between immune cell traits and hemorrhagic stroke using Mendelian randomization (MR).

Methods

We collected genome-wide association studies (GWAS) summary statistics for 731 immune cell traits as exposures, and GWAS data for hemorrhagic stroke outcomes, including intracerebral hemorrhage (ICH), subarachnoid hemorrhage (SAH), and cerebral aneurysm (non-ruptured) (CA), from the FinnGen Consortium's R10 dataset. Five methods were employed to evaluate the causal relationships, with the primary method being the inverse-variance weighted (IVW) method. Sensitivity analyses were carried out to enhance the robustness. Subsequently, we performed multivariate MR analyses, including confounding variables. Additionally, reverse MR analyses were carried out. Ultimately, we conducted pathway and functional enrichment analyses.

Results

After univariate and multivariate MR analyses, we identified that the higher counts of herpesvirus entry mediator (HVEM) on effector memory (EM) CD4+ cells (OR=0.954, 95%CI:0.925-0.984, =0.003, =0.120) were a protective factor for SAH, and the counts of forward scatter area (FSC-A) on plasmacytoid dendritic cells (DC) (OR=1.059, 95%CI:1.023-1.095, =0.001, =0.066) were associated with an increased risk of CA. The reverse MR indicated that CA could significantly increase the effector memory (EM) DN (CD4-CD8-) AC counts. No significant pleiotropy or heterogeneity was calculated in the MR analyses. SNP annotation and enrichment analyses suggested possible mechanisms by which immune cells affect hemorrhagic stroke.

Discussion

The involvement of immune cells in the neuroinflammatory responses has been demonstrated in previous studies. Among the immune cell traits with a significant causal relationship to hemorrhagic stroke, higher levels of HVEM on EM CD4+ cells may inhibit further inflammatory progress by binding to corresponding receptors, thereby exerting a protective effect against SAH. Alterations in FSC-A values (a flow cytometry measure of cell size) of plasmacytoid dendritic cells may contribute to atherosclerosis through cascading reactions that ultimately lead to CA. In addition, based on existing studies, other immune cell traits and related pathways identified in this study may contribute to the prevention and treatment of hemorrhagic stroke, providing a reference for future research. Finally, this study has some limitations, including population specificity, the use of a relatively lenient significance threshold ( < 1 × 10-5), and potential bias from weak instrumental variables and pleiotropy.

Conclusion

This study demonstrated the causal relationships between immune cell traits and hemorrhagic stroke, laying the foundation for understanding the underlying mechanisms.

Loading

Article metrics loading...

/content/journals/cnr/10.2174/0115672026373219250730071202
2025-08-11
2026-03-06
Loading full text...

Full text loading...

References

  1. XuY. ChenA. WuJ. WanY. YouM. GuX. GuoH. TanS. HeQ. HuB. Nanomedicine: An emerging novel therapeutic strategy for hemorrhagic stroke.Int. J. Nanomedicine2022171927195010.2147/IJN.S35759835530973
    [Google Scholar]
  2. BroderickJ.P. GrottaJ.C. NaidechA.M. SteinerT. SpriggN. ToyodaK. DowlatshahiD. DemchukA.M. SelimM. MoccoJ. MayerS. The story of intracerebral hemorrhage.Stroke20215251905191410.1161/STROKEAHA.121.03348433827245
    [Google Scholar]
  3. LawtonM.T. VatesG.E. Subarachnoid hemorrhage.N. Engl. J. Med.2017377325726610.1056/NEJMcp160582728723321
    [Google Scholar]
  4. OhashiS.N. DeLongJ.H. KozbergM.G. Mazur-HartD.J. van VeluwS.J. AlkayedN.J. SansingL.H. Role of inflammatory processes in hemorrhagic stroke.Stroke202354260561910.1161/STROKEAHA.122.03715536601948
    [Google Scholar]
  5. FeiginV.L. StarkB.A. JohnsonC.O. RothG.A. BisignanoC. AbadyG.G. AbbasifardM. Abbasi-KangevariM. Abd-AllahF. AbediV. AbualhasanA. Abu-RmeilehN.M.E. AbushoukA.I. AdebayoO.M. AgarwalG. AgasthiP. AhinkorahB.O. AhmadS. AhmadiS. Ahmed SalihY. AjiB. AkbarpourS. AkinyemiR.O. Al HamadH. AlahdabF. AlifS.M. AlipourV. AljunidS.M. AlmustanyirS. Al-RaddadiR.M. Al-Shahi SalmanR. Alvis-GuzmanN. AncuceanuR. AnderliniD. AndersonJ.A. AnsarA. AntonazzoI.C. ArablooJ. ÄrnlövJ. ArtantiK.D. AryanZ. AsgariS. AshrafT. AtharM. AtreyaA. AusloosM. BaigA.A. BaltatuO.C. BanachM. BarbozaM.A. Barker-ColloS.L. BärnighausenT.W. BaroneM.T.U. BasuS. BazmandeganG. BeghiE. BeheshtiM. BéjotY. BellA.W. BennettD.A. BensenorI.M. BezabheW.M. BezabihY.M. BhagavathulaA.S. BhardwajP. BhattacharyyaK. BijaniA. BikbovB. BirhanuM.M. BoloorA. BonnyA. BrauerM. BrennerH. BryazkaD. ButtZ.A. Caetano dos SantosF.L. Campos-NonatoI.R. Cantu-BritoC. CarreroJ.J. Castañeda-OrjuelaC.A. CatapanoA.L. ChakrabortyP.A. CharanJ. ChoudhariS.G. ChowdhuryE.K. ChuD-T. ChungS-C. ColozzaD. CostaV.M. CostanzoS. CriquiM.H. DadrasO. DagnewB. DaiX. DalalK. DamascenoA.A.M. D’AmicoE. DandonaL. DandonaR. Darega GelaJ. DavletovK. De la Cruz-GóngoraV. DesaiR. DhamnetiyaD. DharmaratneS.D. DhimalM.L. DhimalM. DiazD. DichgansM. DokovaK. DoshiR. DouiriA. DuncanB.B. EftekharzadehS. EkholuenetaleM. El NahasN. ElgendyI.Y. ElhadiM. El-JaafaryS.I. EndresM. EndriesA.Y. ErkuD.A. FaraonE.J.A. FarooqueU. FarzadfarF. FerozeA.H. FilipI. FischerF. FloodD. GadM.M. GaidhaneS. Ghanei GheshlaghR. GhashghaeeA. GhithN. GhozaliG. GhozyS. GialluisiA. GiampaoliS. GilaniS.A. GillP.S. GnedovskayaE.V. GolechhaM. GoulartA.C. GuoY. GuptaR. GuptaV.B. GuptaV.K. GyanwaliP. Hafezi-NejadN. HamidiS. HanifA. HankeyG.J. HargonoA. HashiA. HassanT.S. HassenH.Y. HavmoellerR.J. HayS.I. HayatK. HegazyM.I. HerteliuC. HollaR. HostiucS. HousehM. HuangJ. HumayunA. HwangB-F. IacovielloL. IavicoliI. IbitoyeS.E. IlesanmiO.S. IlicI.M. IlicM.D. IqbalU. IrvaniS.S.N. IslamS.M.S. IsmailN.E. IsoH. IsolaG. IwagamiM. JacobL. JainV. JangS-I. JayapalS.K. JayaramS. JayawardenaR. JeemonP. JhaR.P. JohnsonW.D. JonasJ.B. JosephN. JozwiakJ.J. JürissonM. KalaniR. KalhorR. KalkondeY. KamathA. KamiabZ. KanchanT. KandelH. KarchA. KatotoP.D.M.C. KayodeG.A. KeshavarzP. KhaderY.S. KhanE.A. KhanI.A. KhanM. KhanM.A.B. KhatibM.N. KhubchandaniJ. KimG.R. KimM.S. KimY.J. KisaA. KisaS. KivimäkiM. KolteD. KoolivandA. Koulmane LaxminarayanaS.L. KoyanagiA. KrishanK. KrishnamoorthyV. KrishnamurthiR.V. KumarG.A. KusumaD. La VecchiaC. LaceyB. LakH.M. LallukkaT. LasradoS. LavadosP.M. LeonardiM. LiB. LiS. LinH. LinR-T. LiuX. LoW.D. LorkowskiS. LucchettiG. Lutzky SauteR. Magdy Abd El RazekH. MagnaniF.G. MahajanP.B. MajeedA. MakkiA. MalekzadehR. MalikA.A. ManafiN. MansourniaM.A. MantovaniL.G. MartiniS. MazzagliaG. MehndirattaM.M. MenezesR.G. MeretojaA. MershaA.G. Miao JonassonJ. MiazgowskiB. MiazgowskiT. MichalekI.M. MirrakhimovE.M. MohammadY. Mohammadian-HafshejaniA. MohammedS. MokdadA.H. MokhayeriY. MolokhiaM. MoniM.A. MontasirA.A. MoradzadehR. MorawskaL. MorzeJ. MuruetW. MusaK.I. NagarajanA.J. NaghaviM. Narasimha SwamyS. NascimentoB.R. NegoiR.I. Neupane KandelS. NguyenT.H. NorrvingB. NoubiapJ.J. NwatahV.E. OanceaB. OdukoyaO.O. OlagunjuA.T. OrruH. OwolabiM.O. PadubidriJ.R. PanaA. ParekhT. ParkE-C. Pashazadeh KanF. PathakM. PeresM.F.P. PerianayagamA. PhamT-M. PiradovM.A. PodderV. PolinderS. PostmaM.J. PourshamsA. RadfarA. RafieiA. RaggiA. RahimF. Rahimi-MovagharV. RahmanM. RahmanM.A. RahmaniA.M. RajaiN. RanasingheP. RaoC.R. RaoS.J. RathiP. RawafD.L. RawafS. ReitsmaM.B. RenjithV. RenzahoA.M.N. RezapourA. RodriguezJ.A.B. RoeverL. RomoliM. RynkiewiczA. SaccoS. SadeghiM. Saeedi MoghaddamS. SahebkarA. Saif-Ur-RahmanK.M. SalahR. SamaeiM. SamyA.M. SantosI.S. Santric-MilicevicM.M. SarrafzadeganN. SathianB. SattinD. SchiavolinS. SchlaichM.P. SchmidtM.I. SchutteA.E. SepanlouS.G. SeylaniA. ShaF. ShahabiS. ShaikhM.A. ShannawazM. ShawonM.S.R. SheikhA. SheikhbahaeiS. ShibuyaK. SiabaniS. SilvaD.A.S. SinghJ.A. SinghJ.K. SkryabinV.Y. SkryabinaA.A. SobaihB.H. StorteckyS. StrangesS. TadesseE.G. TariganI.U. TemsahM-H. TeuschlY. ThriftA.G. TonelliM. Tovani-PaloneM.R. TranB.X. TripathiM. TsegayeG.W. UllahA. UnimB. UnnikrishnanB. VakilianA. Valadan TahbazS. VasankariT.J. VenketasubramanianN. VervoortD. VoB. VoloviciV. VosoughiK. VuG.T. VuL.G. WafaH.A. WaheedY. WangY. WijeratneT. WinklerA.S. WolfeC.D.A. WoodwardM. WuJ.H. Wulf HansonS. XuX. YadavL. YadollahpourA. Yahyazadeh JabbariS.H. YamagishiK. YatsuyaH. YonemotoN. YuC. YunusaI. ZamanM.S. ZamanS.B. ZamanianM. ZandR. ZandifarA. ZastrozhinM.S. ZastrozhinaA. ZhangY. ZhangZ-J. ZhongC. ZunigaY.M.H. MurrayC.J.L. GBD 2019 Stroke Collaborators Global, regional, and national burden of stroke and its risk factors, 1990–2019: A systematic analysis for the Global Burden of Disease Study 2019.Lancet Neurol.2021201079582010.1016/S1474‑4422(21)00252‑034487721
    [Google Scholar]
  6. OwolabiM.O. ThriftA.G. MahalA. IshidaM. MartinsS. JohnsonW.D. PandianJ. Abd-AllahF. YariaJ. PhanH.T. RothG. GallS.L. BeareR. PhanT.G. MikulikR. AkinyemiR.O. NorrvingB. BraininM. FeiginV.L. AbantoC. AberaS.F. AddissieA. AdebayoO. AdeleyeA.O. AdilbekovY. AdilbekovaB. AdoukonouT.A. Aguiar de SousaD. AjagbeT. AkhmetzhanovaZ. AkpaluA. Álvarez AhlgrenJ. AmerisoS. AndonovaS. AwoniyiF.E. BakhietM. BarbozaM. BasriH. BathP. BelloO. BereczkiD. BerettaS. BerkowitzA. Bernabé-OrtizA. BernhardtJ. BerzinaG. BisharyanM. BovetP. BudincevicH. CadilhacD. CasoV. ChenC. ChinJ. ChwojnickiK. ConfortoA. CruzV.T. D’AmelioM. DanielyanK. DavisS. DemarinV. DempseyR. DichgansM. DokovaK. DonnanG. ElkindM.S. EndresM. FischerU. GankpéF. Gaye SaavedraA. GilA. GiroudM. GnedovskayaE. HachinskiV. HafdiM. HamadehR. HamzatT.K. HankeyG. HeldnerM. IbrahimE.A. IbrahimN.M. InoueM. JeeS. JengJ-S. KalkondeY. KamenovaS. KaraszewskiB. KellyP. KhanT. KiechlS. KondybayevaA. KõrvJ. KravchenkoM. KrishnamurthiR.V. KrujaJ. LakkhanaloetM. LanghorneP. LavadosP.M. LawZ.K. LawalA. Lazo-PorrasM. LebedynetsD. LeeT-H. LeungT. LiebeskindD.S. LindsayP. López-JaramilloP. LotufoP.A. Machline-CarrionJ. MakanjuolaA. MarkusH.S. Marquez-RomeroJ.M. MedinaM. MedukhanovaS. MehndirattaM.M. MerkinA. MirrakhimovE. MohlS. Moscoso-PorrasM. Müller-StierlinA. MurphyS. MusaK.I. NasreldeinA. NogueiraR.G. NolteC. NoubiapJ.J. Novarro-EscuderoN. OgunY. OguntoyeR.A. OrabyM.I. OsundinaM. OvbiageleB. OrkenD.N. OzdemirA.Ö. OzturkS. PaccotM. PhromjaiJ. PiradovP. PlatzT. PotparaT. RantaA. RathoreF. RichardE. SaccoR.L. SahathevanR. Santos CarquínI. SaposnikG. SarfoF.S. SharmaM. ShethK. ShobhanaA. SuwanwelaN. SvyatoI. SylajaP.N. TaoX. ThakurK.T. ToniD. TopcuogluM.A. ToralesJ. TowfighiA. TruelsenT.C. TsiskaridzeA. Tulloch-ReidM. UsecheN. VanackerP. VassilopoulouS. VukorepaG. VuleticV. WahabK.W. WangW. WijeratneT. WolfeC. YifruY.M. Yock-CorralesA. YonemotoN. YperzeeleL. ZhangP. Stroke Experts Collaboration Group Primary stroke prevention worldwide: Translating evidence into action.Lancet Public Health202271e74e8510.1016/S2468‑2667(21)00230‑934756176
    [Google Scholar]
  7. AlsbrookD.L. Di NapoliM. BhatiaK. BillerJ. AndalibS. HindujaA. RodriguesR. RodriguezM. SabbaghS.Y. SelimM. FarahabadiM.H. JafarliA. DivaniA.A. Neuroinflammation in acute ischemic and hemorrhagic stroke.Curr. Neurol. Neurosci. Rep.202323840743110.1007/s11910‑023‑01282‑237395873
    [Google Scholar]
  8. DaëronM. The immune system as a system of relations.Front. Immunol.20221398467810.3389/fimmu.2022.98467836177051
    [Google Scholar]
  9. MaloneK. AmuS. MooreA.C. WaeberC. The immune system and stroke: From current targets to future therapy.Immunol. Cell Biol.201997151610.1111/imcb.1219130022515
    [Google Scholar]
  10. JiangC. WangY. HuQ. ShouJ. ZhuL. TianN. SunL. LuoH. ZuoF. LiF. WangY. ZhangJ. WangJ. WangJ. ZhangJ. Immune changes in peripheral blood and hematoma of patients with intracerebral hemorrhage.FASEB J.20203422774279110.1096/fj.201902478R31912591
    [Google Scholar]
  11. Zeyu Zhang Yuanjian Fang Cameron Lenahan Sheng Chen The role of immune inflammation in aneurysmal subarachnoid hemorrhage.Exp. Neurol.202133611353510.1016/j.expneurol.2020.11353533249033
    [Google Scholar]
  12. ZhaoZ. PanZ. ZhangS. MaG. ZhangW. SongJ. WangY. KongL. DuG. Neutrophil extracellular traps: A novel target for the treatment of stroke.Pharmacol. Ther.202324110832810.1016/j.pharmthera.2022.10832836481433
    [Google Scholar]
  13. IadecolaC. BuckwalterM.S. AnratherJ. Immune responses to stroke: Mechanisms, modulation, and therapeutic potential.J. Clin. Invest.202013062777278810.1172/JCI13553032391806
    [Google Scholar]
  14. ZhangB.W. SunK.H. LiuT. ZouW. The crosstalk between immune cells after intracerebral hemorrhage.Neuroscience20245379310410.1016/j.neuroscience.2023.11.01538056621
    [Google Scholar]
  15. LarssonS.C. ButterworthA.S. BurgessS. Mendelian randomization for cardiovascular diseases: Principles and applications.Eur. Heart J.202344474913492410.1093/eurheartj/ehad73637935836
    [Google Scholar]
  16. FerenceB.A. HolmesM.V. SmithG.D. Using mendelian randomization to improve the design of randomized trials.Cold Spring Harb. Perspect. Med.2021117a04098010.1101/cshperspect.a04098033431510
    [Google Scholar]
  17. de LeeuwC. SavageJ. BucurI.G. HeskesT. PosthumaD. Understanding the assumptions underlying Mendelian randomization.Eur. J. Hum. Genet.202230665366010.1038/s41431‑022‑01038‑535082398
    [Google Scholar]
  18. SkrivankovaV.W. RichmondR.C. WoolfB.A.R. YarmolinskyJ. DaviesN.M. SwansonS.A. VanderWeeleT.J. HigginsJ.P.T. TimpsonN.J. DimouN. LangenbergC. GolubR.M. LoderE.W. GalloV. Tybjaerg-HansenA. Davey SmithG. EggerM. RichardsJ.B. Strengthening the reporting of observational studies in epidemiology using mendelian randomization.JAMA2021326161614162110.1001/jama.2021.1823634698778
    [Google Scholar]
  19. OrrùV. SteriM. SidoreC. MarongiuM. SerraV. OllaS. SoleG. LaiS. DeiM. MulasA. VirdisF. PirasM.G. LobinaM. MarongiuM. PitzalisM. DeiddaF. LoizeddaA. OnanoS. ZoledziewskaM. SawcerS. DevotoM. GorospeM. AbecasisG.R. FlorisM. PalaM. SchlessingerD. FiorilloE. CuccaF. Complex genetic signatures in immune cells underlie autoimmunity and inform therapy.Nat. Genet.202052101036104510.1038/s41588‑020‑0684‑432929287
    [Google Scholar]
  20. ShenY. LiuH. MengX. GaoA. LiuY. MaW. LiangH. HuF. The causal effects between gut microbiota and hemorrhagic stroke: A bidirectional two-sample Mendelian randomization study.Front. Microbiol.202314129090910.3389/fmicb.2023.129090938188561
    [Google Scholar]
  21. ZhangX. ZhuX. ShiQ. The plasma lipids with different fatty acid chains are associated with the risk of hemorrhagic stroke: A Mendelian randomization study.Front. Neurol.202415143287810.3389/fneur.2024.143287839139767
    [Google Scholar]
  22. CaoR.R. YuX.H. XiongM.F. LiX.T. DengF.Y. LeiS.F. The immune factors have complex causal regulation effects on bone mineral density.Front. Immunol.20221395941710.3389/fimmu.2022.95941736341399
    [Google Scholar]
  23. HanX. WangJ. SuX. GuoX. YeH. Exploring the causal influence of 731 immune cells on 4 different glaucoma subtypes using a two-sample mendelian randomization method.Sci. Rep.2025151598710.1038/s41598‑025‑90545‑839966504
    [Google Scholar]
  24. LiP. WangH. GuoL. GouX. ChenG. LinD. FanD. GuoX. LiuZ. Association between gut microbiota and preeclampsia-eclampsia: A two-sample Mendelian randomization study.BMC Med.202220144310.1186/s12916‑022‑02657‑x36380372
    [Google Scholar]
  25. BurgessS. ThompsonS.G. CRP CHD Genetics Collaboration Avoiding bias from weak instruments in Mendelian randomization studies.Int. J. Epidemiol.201140375576410.1093/ije/dyr03621414999
    [Google Scholar]
  26. HemaniG. ZhengJ. ElsworthB. WadeK.H. HaberlandV. BairdD. LaurinC. BurgessS. BowdenJ. LangdonR. TanV.Y. YarmolinskyJ. ShihabH.A. TimpsonN.J. EvansD.M. ReltonC. MartinR.M. Davey SmithG. GauntT.R. HaycockP.C. The MR-Base platform supports systematic causal inference across the human phenome.eLife2018307e3440810.7554/eLife.3440829846171
    [Google Scholar]
  27. RanB. QinJ. WuY. WenF. Causal role of immune cells in chronic obstructive pulmonary disease: Mendelian randomization study.Expert Rev. Clin. Immunol.202420441342110.1080/1744666X.2023.229598738108202
    [Google Scholar]
  28. BurgessS. BowdenJ. FallT. IngelssonE. ThompsonS.G. Sensitivity analyses for robust causal inference from mendelian randomization analyses with multiple genetic variants.Epidemiology2017281304210.1097/EDE.000000000000055927749700
    [Google Scholar]
  29. YeX. LiuB. BaiY. CaoY. LinS. LyuL. MengH. DaiY. YeD. PanW. WangZ. MaoY. ChenQ. Genetic evidence strengthens the bidirectional connection between gut microbiota and periodontitis: Insights from a two-sample Mendelian randomization study.J. Transl. Med.202321167410.1186/s12967‑023‑04559‑937770955
    [Google Scholar]
  30. BurgessS. Davey SmithG. DaviesN.M. DudbridgeF. GillD. GlymourM.M. HartwigF.P. KutalikZ. HolmesM.V. MinelliC. MorrisonJ.V. PanW. ReltonC.L. TheodoratouE. Guidelines for performing Mendelian randomization investigations: Update for summer 2023.Wellcome Open Res.2019418610.12688/wellcomeopenres.15555.332760811
    [Google Scholar]
  31. ChenX. KongJ. DiaoX. CaiJ. ZhengJ. XieW. QinH. HuangJ. LinT. Depression and prostate cancer risk: A Mendelian randomization study.Cancer Med.20209239160916710.1002/cam4.349333027558
    [Google Scholar]
  32. KolbergL. RaudvereU. KuzminI. AdlerP. ViloJ. PetersonH. g:Profiler—interoperable web service for functional enrichment analysis and gene identifier mapping (2023 update).Nucleic Acids Res.202351W1W207W21210.1093/nar/gkad34737144459
    [Google Scholar]
  33. MaY. YangS. HeQ. ZhangD. ChangJ. The role of immune cells in post-stroke angiogenesis and neuronal remodeling: The known and the unknown.Front. Immunol.20211278409810.3389/fimmu.2021.78409834975872
    [Google Scholar]
  34. LiX. ChenG. CNS-peripheral immune interactions in hemorrhagic stroke.J. Cereb. Blood Flow Metab.202343218519710.1177/0271678X22114508936476130
    [Google Scholar]
  35. ChenS. LiL. PengC. BianC. OcakP.E. ZhangJ.H. YangY. ZhouD. ChenG. LuoY. Targeting oxidative stress and inflammatory response for blood–brain barrier protection in intracerebral hemorrhage.Antioxid. Redox Signal.2022371-311513410.1089/ars.2021.007235383484
    [Google Scholar]
  36. GuoY. DaiW. ZhengY. QiaoW. ChenW. PengL. ZhouH. ZhaoT. LiuH. ZhengF. SunP. Mechanism and regulation of microglia polarization in intracerebral hemorrhage.Molecules20222720708010.3390/molecules2720708036296682
    [Google Scholar]
  37. DongH. WenX. ZhangB.W. WuZ. ZouW. Astrocytes in intracerebral hemorrhage: Impact and therapeutic objectives.Front. Mol. Neurosci.202417132747210.3389/fnmol.2024.132747238419793
    [Google Scholar]
  38. LeeT.H. LiuP.S. TsaiM.M. ChenJ.L. WangS.J. HsiehH.L. The COX-2-derived PGE2 autocrine contributes to bradykinin-induced matrix metalloproteinase-9 expression and astrocytic migration via STAT3 signaling.Cell Commun. Signal.202018118510.1186/s12964‑020‑00680‑033228717
    [Google Scholar]
  39. TschoeC. BushnellC.D. DuncanP.W. Alexander-MillerM.A. WolfeS.Q. Neuroinflammation after intracerebral hemorrhage and potential therapeutic targets.J. Stroke2020221294610.5853/jos.2019.0223632027790
    [Google Scholar]
  40. ChaudhryS.R. KahlertU.D. KinfeT.M. EndlE. DolfA. NiemeläM. HänggiD. MuhammadS. Differential polarization and activation dynamics of systemic T helper cell subsets after aneurysmal subarachnoid hemorrhage (SAH) and during post-SAH complications.Sci. Rep.20211111422610.1038/s41598‑021‑92873‑x34244562
    [Google Scholar]
  41. LauzierD.C. AthiramanU. Role of microglia after subarachnoid hemorrhage.J. Cereb. Blood Flow Metab.202444684185610.1177/0271678X24123707038415607
    [Google Scholar]
  42. LiuY. ChenS. LiuS. WallaceK.L. ZilleM. ZhangJ. WangJ. JiangC. T-cell receptor signaling modulated by the co-receptors: Potential targets for stroke treatment.Pharmacol. Res.202319210679710.1016/j.phrs.2023.10679737211238
    [Google Scholar]
  43. StanzioneR. ForteM. CotugnoM. BianchiF. MarchittiS. RubattuS. Role of DAMPs and of leukocytes infiltration in ischemic stroke: Insights from animal models and translation to the human disease.Cell. Mol. Neurobiol.202242354555610.1007/s10571‑020‑00966‑432996044
    [Google Scholar]
  44. ZhangD. RenJ. LuoY. HeQ. ZhaoR. ChangJ. YangY. GuoZ.N. T cell response in ischemic stroke: From mechanisms to translational insights.Front. Immunol.20211270797210.3389/fimmu.2021.70797234335623
    [Google Scholar]
  45. GongZ. GuoJ. LiuB. GuoY. ChengC. JiangY. LiangN. HuM. SongT. YangL. LiH. ZhangH. ZongX. CheQ. ShiN. Mechanisms of immune response and cell death in ischemic stroke and their regulation by natural compounds.Front. Immunol.202414128785710.3389/fimmu.2023.128785738274789
    [Google Scholar]
  46. RayasamA. HsuM. KijakJ.A. KisselL. HernandezG. SandorM. FabryZ. Immune responses in stroke: how the immune system contributes to damage and healing after stroke and how this knowledge could be translated to better cures?Immunology2018154336337610.1111/imm.1291829494762
    [Google Scholar]
  47. WangK. ZhangB. LiM. DuanH. JiangZ. GaoS. ChenJ. FangS. Evaluation of the causal effects of immune cells on ischemic stroke: A Mendelian randomization study.Front. Immunol.202415137435010.3389/fimmu.2024.137435038855113
    [Google Scholar]
  48. ShiS.X. XiuY. LiY. YuanM. ShiK. LiuQ. WangX. JinW.N. CD4+ T cells aggravate hemorrhagic brain injury.Sci. Adv.2023923eabq071210.1126/sciadv.abq071237285421
    [Google Scholar]
  49. ZhongQ. ZhouK. LiangQ.L. LinS. WangY.C. XiongX.Y. MengZ.Y. ZhaoT. ZhuW.Y. YangY.R. LiaoM.F. GongQ.W. LiuL. XiongA. HaoJ. WangJ. YangQ.W. Interleukin-23 secreted by activated macrophages drives γδT cell production of interleukin-17 to aggravate secondary injury after intracerebral hemorrhage.J. Am. Heart Assoc.2016510e00434010.1161/JAHA.116.00434027729335
    [Google Scholar]
  50. YeL. ChengH-W. GaoL. LiP-P. ShaoT-Y. MaoX. QiH. WuB-S. ShanM. Neurotoxic role of interleukin-17 in neural stem cell differentiation after intracerebral hemorrhage.Neural Regen. Res.20201571350135910.4103/1673‑5374.27261431960824
    [Google Scholar]
  51. SeoG.Y. ShuiJ.W. TakahashiD. SongC. WangQ. KimK. MikulskiZ. ChandraS. GilesD.A. ZahnerS. KimP.H. CheroutreH. ColonnaM. KronenbergM. LIGHT-HVEM signaling in innate lymphoid cell subsets protects against enteric bacterial infection.Cell Host Microbe2018242249260.e410.1016/j.chom.2018.07.00830092201
    [Google Scholar]
  52. LiuW. ChouT.F. Garrett-ThomsonS.C. SeoG.Y. FedorovE. RamagopalU.A. BonannoJ.B. WangQ. KimK. GarforthS.J. KakugawaK. CheroutreH. KronenbergM. AlmoS.C. HVEM structures and mutants reveal distinct functions of binding to LIGHT and BTLA/CD160.J. Exp. Med.202121812e2021111210.1084/jem.2021111234709351
    [Google Scholar]
  53. YuX. ZhengY. MaoR. SuZ. ZhangJ. BTLA/HVEM signaling: Milestones in research and role in chronic hepatitis B virus infection.Front. Immunol.20191061710.3389/fimmu.2019.0061730984188
    [Google Scholar]
  54. Rodriguez-BarbosaJ.I. SchneiderP. WeigertA. LeeK.M. KimT.J. Perez-SimonJ.A. del RioM.L. HVEM, a cosignaling molecular switch, and its interactions with BTLA, CD160 and LIGHT.Cell. Mol. Immunol.201916767968210.1038/s41423‑019‑0241‑131160757
    [Google Scholar]
  55. WakeleyM.E. ArmsteadB.E. GrayC.C. TindalE.W. HeffernanD.S. ChungC.S. AyalaA. Lymphocyte HVEM/BTLA co-expression after critical illness demonstrates severity indiscriminate upregulation, impacting critical illness-induced immunosuppression.Front. Med. (Lausanne)202310117660210.3389/fmed.2023.117660237305124
    [Google Scholar]
  56. SalvadorA.F.M. AbduljawadN. KipnisJ. Meningeal lymphatics in central nervous system diseases.Annu. Rev. Neurosci.202447132334410.1146/annurev‑neuro‑113023‑10304538648267
    [Google Scholar]
  57. FitzpatrickZ. Ghabdan ZanluquiN. RosenblumJ.S. TuongZ.K. LeeC.Y.C. ChandrashekharV. Negro-DemontelM.L. StewartA.P. PosnerD.A. BuckleyM. AllinsonK.S.J. MastorakosP. ChittiboinaP. MaricD. DonahueD. HelmyA. TajsicT. FerdinandJ.R. PortetA. PeñalverA. GillmanE. ZhuangZ. ClatworthyM.R. McGavernD.B. Venous-plexus-associated lymphoid hubs support meningeal humoral immunity.Nature2024628800861261910.1038/s41586‑024‑07202‑938509366
    [Google Scholar]
  58. BalanS. SaxenaM. BhardwajN. Dendritic cell subsets and locations.Int. Rev. Cell Mol. Biol.201934816810.1016/bs.ircmb.2019.07.00431810551
    [Google Scholar]
  59. TsymbalyukO. GerzanichV. SimardJ.M. RathinamC.V. Traumatic brain injury alters dendritic cell differentiation and distribution in lymphoid and non-lymphoid organs.J. Neuroinflammation202219123810.1186/s12974‑022‑02609‑536183126
    [Google Scholar]
  60. SomebangK. RudolphJ. ImhofI. LiL. NiemiE.C. ShigenagaJ. TranH. GillT.M. LoI. ZabelB.A. SchmajukG. WipkeB.T. GyonevaS. JandreskiL. CraftM. BenedettoG. PloweyE.D. CharoI. CampbellJ. YeC.J. PanterS.S. NakamuraM.C. EckalbarW. HsiehC.L. CCR2 deficiency alters activation of microglia subsets in traumatic brain injury.Cell Rep.2021361210972710.1016/j.celrep.2021.10972734551293
    [Google Scholar]
  61. ChenC. ChenchengZ. CuiyingL. XiaokunG. Plasmacytoid dendritic cells protect against middle cerebral artery occlusion induced brain injury by priming regulatory T cells.Front. Cell. Neurosci.202014810.3389/fncel.2020.0000832076400
    [Google Scholar]
  62. Ah KioonM.D. LaurentP. ChaudharyV. DuY. CrowM.K. BarratF.J. Modulation of plasmacytoid dendritic cells response in inflammation and autoimmunity.Immunol. Rev.2024323124125610.1111/imr.1333138553621
    [Google Scholar]
  63. AdamsN.M. DasA. YunT.J. ReizisB. Ontogeny and Function of Plasmacytoid Dendritic Cells.Annu. Rev. Immunol.202442134737310.1146/annurev‑immunol‑090122‑04110538941603
    [Google Scholar]
  64. FrishbergA. KooistraE. Nuesch-GermanoM. PechtT. MilmanN. ReuschN. Warnat-HerresthalS. BruseN. HändlerK. TheisH. KrautM. van RijssenE. van CranenbroekB. KoenenH.J.P.M. HeesakkersH. van den BoogaardM. ZegersM. PickkersP. BeckerM. AschenbrennerA.C. UlasT. TheisF.J. Shen-OrrS.S. SchultzeJ.L. KoxM. Mature neutrophils and a NF-κB-to-IFN transition determine the unifying disease recovery dynamics in COVID-19.Cell Rep. Med.20223610065210.1016/j.xcrm.2022.10065235675822
    [Google Scholar]
  65. SageA.P. MurphyD. MaffiaP. MastersL.M. SabirS.R. BakerL.L. CambrookH. FiniganA.J. Ait-OufellaH. GrassiaG. HarrisonJ.E. LudewigB. ReithW. HanssonG.K. ReizisB. HuguesS. MallatZ. MHC Class II-restricted antigen presentation by plasmacytoid dendritic cells drives proatherogenic T cell immunity.Circulation2014130161363137310.1161/CIRCULATIONAHA.114.01109025223984
    [Google Scholar]
  66. YoungL.J. WilsonN.S. SchnorrerP. ProiettoA. ten BroekeT. MatsukiY. MountA.M. BelzG.T. O’KeeffeM. Ohmura-HoshinoM. IshidoS. StoorvogelW. HeathW.R. ShortmanK. VilladangosJ.A. Differential MHC class II synthesis and ubiquitination confers distinct antigen-presenting properties on conventional and plasmacytoid dendritic cells.Nat. Immunol.20089111244125210.1038/ni.166518849989
    [Google Scholar]
  67. WangM. ThomsonA.W. YuF. HazraR. JunagadeA. HuX. Regulatory T lymphocytes as a therapy for ischemic stroke.Semin. Immunopathol.202345332934610.1007/s00281‑022‑00975‑z36469056
    [Google Scholar]
  68. LiN. WangH. HuC. QieS. LiuZ. RegulatoryT. Regulatory T cells for stroke recovery: A promising immune therapeutic strategy.CNS Neurosci. Ther.2025311e7024810.1111/cns.7024839878387
    [Google Scholar]
  69. ZhengY. RenZ. LiuY. YanJ. ChenC. HeY. ShiY. ChengF. WangQ. LiC. WangX. T cell interactions with microglia in immune-inflammatory processes of ischemic stroke.Neural Regen. Res.20252051277129210.4103/NRR.NRR‑D‑23‑0138539075894
    [Google Scholar]
  70. RikhtegarR. YousefiM. DolatiS. KasmaeiH.D. CharsoueiS. NouriM. ShakouriS.K. Stem cell-based cell therapy for neuroprotection in stroke: A review.J. Cell. Biochem.201912068849886210.1002/jcb.2820730506720
    [Google Scholar]
  71. EllisG.I. SheppardN.C. RileyJ.L. Genetic engineering of T cells for immunotherapy.Nat. Rev. Genet.202122742744710.1038/s41576‑021‑00329‑933603158
    [Google Scholar]
  72. StephensR. GraingerJ.R. SmithC.J. AllanS.M. Systemic innate myeloid responses to acute ischaemic and haemorrhagic stroke.Semin. Immunopathol.202345328129410.1007/s00281‑022‑00968‑y36346451
    [Google Scholar]
  73. CantatoreF.P. MaruottiN. CorradoA. RibattiD. Anti-angiogenic effects of biotechnological therapies in rheumatic diseases.Biologics20171112312829276377
    [Google Scholar]
  74. AoLY YanYY ZhouL Immune cells after ischemic stroke Onset: Roles, migration, and target intervention.J Mol Neurosci201866334235510.1007/s12031‑018‑1173‑430267340
    [Google Scholar]
  75. WarehamL.K. BarattaR.O. Del BuonoB.J. SchlumpfE. CalkinsD.J. Collagen in the central nervous system: Contributions to neurodegeneration and promise as a therapeutic target.Mol. Neurodegener.20241911110.1186/s13024‑024‑00704‑038273335
    [Google Scholar]
  76. LinW. WangY. ChenY. WangQ. GuZ. ZhuY. Role of calcium signaling pathway-related gene regulatory networks in ischemic stroke based on multiple WGCNA and single-cell analysis.Oxid. Med. Cell. Longev.202120211806047710.1155/2021/806047734987704
    [Google Scholar]
/content/journals/cnr/10.2174/0115672026373219250730071202
Loading
/content/journals/cnr/10.2174/0115672026373219250730071202
Loading

Data & Media loading...

Supplements

Supplementary material is available on the publisher's website along with the published article.

This is a required field
Please enter a valid email address
Approval was a Success
Invalid data
An Error Occurred
Approval was partially successful, following selected items could not be processed due to error
Please enter a valid_number test